BusinessWeek Logo

Magazine

Featured Video

screenshot from featured video

Reinventing R&D at Novartis

Novartis CEO Daniel Vasella talks about his seven-year effort, which is now bearing fruit, to overhaul Novartis' R&D by focusing on rare diseases for the next blockbuster drugs

The Debate Room

image of columnist

Tax Sugary Soft Drinks

The federal government should help finance the expansion of U.S. health coverage by taxing products, such as sugary soft drinks, that contribute to obesity and other chronic health conditions. Pro or Con?

 

BW Mall - Sponsored Links

Buy a link now!

Top Stories

Novartis: Radically Remaking Its Drug Business

CEO Dan Vasella's growth mantra for Novartis is follow the science, not the financials

Companies Willing to Take Risks in a Recession

Some global companies, from Fiat to Oracle to Toys 'R' Us, are taking advantage of the downturn by making gutsy moves that are likely to pay off later

Turning Failure into Success

Automated innovation—relying on computers to roll out new products—flopped at first. Now it's come back as a cost-cutting tool for hard times

IN YOUR FACE: A PALL OVER PALM’S PRE

image of columnist

Reader Perlgoon Writes:

"I was looking forward to upgrading from Treo 650. I went to the Sprint store. None in stock. Best Buy? None in stock. Money burning a hole in my pocket and I can't spend ."


Sponsored by Tres Generaciones Tequila

 

The Welch Way

image of columnist

The Difference Dignity Makes

If this sounds warm and fuzzy, keep in mind that it's also about winning